GB201003124D0 - Treatment of oxidative stress disorders - Google Patents
Treatment of oxidative stress disordersInfo
- Publication number
- GB201003124D0 GB201003124D0 GBGB1003124.3A GB201003124A GB201003124D0 GB 201003124 D0 GB201003124 D0 GB 201003124D0 GB 201003124 A GB201003124 A GB 201003124A GB 201003124 D0 GB201003124 D0 GB 201003124D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- oxidative stress
- stress disorders
- disorders
- oxidative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1003124.3A GB201003124D0 (en) | 2010-02-25 | 2010-02-25 | Treatment of oxidative stress disorders |
| PCT/GB2011/050386 WO2011104568A1 (en) | 2010-02-25 | 2011-02-25 | Treatment of oxidative stress disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1003124.3A GB201003124D0 (en) | 2010-02-25 | 2010-02-25 | Treatment of oxidative stress disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201003124D0 true GB201003124D0 (en) | 2010-04-14 |
Family
ID=42125575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1003124.3A Ceased GB201003124D0 (en) | 2010-02-25 | 2010-02-25 | Treatment of oxidative stress disorders |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201003124D0 (en) |
| WO (1) | WO2011104568A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014117117A1 (en) * | 2013-01-28 | 2014-07-31 | The Johns Hopkins University | Chronic nsaid treatment for fuchs endothelial corneal dystrophy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0419145D0 (en) * | 2004-08-27 | 2004-09-29 | Univ Dundee | Treatment of posterior capsule opacification |
-
2010
- 2010-02-25 GB GBGB1003124.3A patent/GB201003124D0/en not_active Ceased
-
2011
- 2011-02-25 WO PCT/GB2011/050386 patent/WO2011104568A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011104568A1 (en) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL226401A0 (en) | Methods of treating fgf21-associated disorders | |
| ZA201304280B (en) | Treatment of jak2-mediated conditions | |
| IL217901A0 (en) | Treatment of bdnf-related disorders using laquninimod | |
| IL217824A0 (en) | Treatment of of macrophage-related disorders | |
| ZA201205829B (en) | Treatment of respiratory disorders | |
| IL220876A0 (en) | Treatment of cardiac conditions | |
| ZA201301601B (en) | Treatment of diseases | |
| EP2605827A4 (en) | Non-invasive treatment of bronchial constriction | |
| GB201000916D0 (en) | Treatment of biofilms | |
| GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
| IL213502A0 (en) | Treatment of dyskinesia related disorders | |
| IL233111A0 (en) | Treatment of inflammation | |
| IL225896A0 (en) | Treatment of mecp2-associated disorders | |
| ZA201106076B (en) | Treatment of insulin-resistant disorders | |
| IL256026B (en) | Methods of treatment | |
| GB0908101D0 (en) | Treatment of stress | |
| IL223385B (en) | Treatment of inflammatory disorders | |
| GB201107467D0 (en) | Novel treatment of pain | |
| GB201003124D0 (en) | Treatment of oxidative stress disorders | |
| EP2531186A4 (en) | Treatment skin disorders | |
| GB201002842D0 (en) | Treatment of inflammatory disorders | |
| HK1189155A (en) | Treatment of mecp2-associated disorders | |
| GB201001912D0 (en) | Treatment of respiratory disorders | |
| GB201007205D0 (en) | Treatment of joint disorders | |
| IL218684A0 (en) | Peptides for treatment of oxidative stress related disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |